グルココルチコイド治療の最適化:古い槍の鋭さ

Frank Buttgereit¹, Gerd-Rüdiger Burmester, Brian J Lipworth

¹Department of Rheumatology & Clinical Immunology, Charité University Hospital, Berlin, Germany.

Lancet (London, England)

|March 1, 2005

まとめ

グルココルチコイドは,多くの病気を効果的に治療しますが,副作用を引き起こします. 治療の効果を向上させ,リスクを軽減するために,ニトロソグルココルチコイドを含む新薬の開発が必要である.

科学分野:

薬理学薬理学とは
小児内分泌学について
免疫学免疫学とは

背景:

グルココルチコイドは,免疫抑制および抗炎症効果のために広く使用されています.
効果と低コストにもかかわらず,副作用は治療の最適化を必要とします.
以前の研究では,高用量グルココルチコイドを摂取した子供の身長が短く,BMIが上昇したことが示された.

研究の目的:

グルココルチコイド治療の最適化のための戦略をレビューする.
現在のグルココルチコイド療法の限界を特定する.
改善された利益リスク比率のための新しい治療アプローチを探求する.

主な方法:

グルココルチコイド治療戦略に関する文献レビュー.
副作用と治療結果に関する既存のデータの分析.
新薬開発パイプラインの評価.

主要な成果:

従来のグルココルチコイド治療の最適化は限界に達しているようです.
腎不全症候群の小児における高用量グルココルチコイドの使用は,身長が短くなり,BMIが増加した.
骨のミネラル密度の赤字は観察されませんでしたが,おそらくBMIの増加によるものです.

結論:

グルココルチコイド治療の最適化のための現在の戦略は,その限界に近づいています.
ニトロソグルココルチコイドや選択性グルココルチコイド受容体アゴニストなどの新薬の開発は極めて重要です.
改善されたグルココルチコイド療法は,幅広い小児および成人疾患に必要である.

さらに関連する動画

08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

関連する概念動画

01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

関連する実験動画